Idiopathic pulmonary fibrosis (IPF), a fibrosing interstitial pneumonia of unknown etiology,
primarily affects older adults and leads to a progressive decline in lung function and quality …

Idiopathic pulmonary fibrosis (IPF) is defined as a specific form of chronic, progressive
fibrosing interstitial pneumonia of unknown cause, occurring primarily in older adults, and …

Idiopathic pulmonary fibrosis (IPF) is a deadly disease with a median survival of
approximately three years in historical cohorts. Despite increased knowledge of disease …

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterised by chronic,
progressive scarring of the lungs and the pathological hallmark of usual interstitial …

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease of unknown cause,
occurring in adults, limited to the lungs and associated with the pathologic and radiologic …

Several clinical trials have recently targeted specific pathways implicated in the
pathogenesis of idiopathic pulmonary fibrosis (IPF). However, IPF remains plagued by a …

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive lung disease with a prognosis
that can be worse than for many cancers. The initial stages of the condition were thought to …

Over the past two and a half decades, many clinical trials have been designed to determine
the safety and efficacy of pharmacotherapy for patients with idiopathic pulmonary fibrosis …

Idiopathic pulmonary fibrosis (IPF) is a chronic and usually progressive lung disorder of
unknown aetiology. Conventional management of patients with IPF has been primarily …

Despite multiple clinical trials, there is no strong, definitive evidence in favor of any agent to
treat IPF. On the other hand, the placebo arms of these large trials have provided us with …